You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

Drugs Containing Excipient (Inactive Ingredient) THIMEROSAL


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing THIMEROSAL excipient, and estimated key patent expiration / generic entry dates

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
A-S Medication Solutions NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE OTIC SUSPENSION neomycin and polymyxin b sulfates and hydrocortisone otic 50090-6336 THIMEROSAL
Endo Pharmaceuticals Inc CORTISPORIN TC colistin sulfate, neomycin sulfate, thonzonium bromide and hydrocortisone acetate 63481-529 THIMEROSAL
Rising Pharma Holdings Inc NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE OTIC SUSPENSION neomycin and polymyxin b sulfates and hydrocortisone otic 64980-448 THIMEROSAL
Preferred Pharmaceuticals Inc NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE OTIC SUSPENSION neomycin and polymyxin b sulfates and hydrocortisone otic 68788-7787 THIMEROSAL
Casper Pharma LLC CASPORYN HC neomycin and polymyxin b sulfates and hydrocortisone otic 70199-011 THIMEROSAL
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Generic drugs containing THIMEROSAL excipient

Company Ingredient NDC Excipient
Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc coral snake (micrurus fulvius) immune globulin antivenin (equine) 0008-0423 THIMEROSAL
Amphastar Pharmaceuticals Inc hyaluronidase 0548-9090 THIMEROSAL
Grifols USA LLC tetanus and diphtheria toxoids adsorbed 13533-131 THIMEROSAL
MassBiologics tetanus and diphtheria toxoids adsorbed 14362-0111 THIMEROSAL
STAT RX USA LLC neomycin sulfate, polymyxin b sulfate and hydrocortisone 16590-347 THIMEROSAL
Rebel Distributors Corp sulfacetamide sodium and prednisolone sodium phosphate 21695-186 THIMEROSAL
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group